|
Volumn 38, Issue 10, 2002, Pages 1351-1357
|
Baseline quality of life predicts survival in patients with advanced colorectal cancer
|
Author keywords
Clinical trials; Colorectal cancer; Prognosis; Quality of life
|
Indexed keywords
FLUOROURACIL;
INTERFERON;
MITOMYCIN C;
RALTITREXED;
ADULT;
ADVANCED CANCER;
AGED;
APPETITE;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER PAIN;
CANCER SURVIVAL;
CLINICAL TRIAL;
COGNITION;
COHORT ANALYSIS;
COLORECTAL CARCINOMA;
CONSTIPATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DYSPNEA;
FATIGUE;
FEMALE;
FINANCIAL MANAGEMENT;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
NAUSEA;
PREDICTION;
PRIORITY JOURNAL;
PROGNOSIS;
QUALITY OF LIFE;
QUESTIONNAIRE;
RANDOMIZED CONTROLLED TRIAL;
SLEEP DISORDER;
SURVIVAL RATE;
SYMPTOM;
TREATMENT OUTCOME;
VOMITING;
ADULT;
AGED;
AGED, 80 AND OVER;
ANALYSIS OF VARIANCE;
ANTINEOPLASTIC AGENTS;
COHORT STUDIES;
COLORECTAL NEOPLASMS;
FEMALE;
FLUOROURACIL;
HUMANS;
MALE;
MIDDLE AGED;
PROGNOSIS;
PROSPECTIVE STUDIES;
QUALITY OF LIFE;
QUESTIONNAIRES;
QUINAZOLINES;
RANDOMIZED CONTROLLED TRIALS;
THIOPHENES;
|
EID: 0036292003
PISSN: 09598049
EISSN: None
Source Type: Journal
DOI: 10.1016/S0959-8049(02)00098-9 Document Type: Article |
Times cited : (217)
|
References (40)
|